Epilepsy often occurs in Rett syndrome and is considered a major problem. The aim of this study was to define the clinical features of epilepsy and the correlation between seizures and both genotype and clinical phenotype in the Rett population. One hundred sixty-five patients with Rett syndrome referred to four Italian centers were recruited. All patients underwent video/EEG monitoring and molecular analysis of the MECP2 gene or, in negative cases, of the CDKL5 and FOXG1 genes. The frequency of epilepsy was 79%. Drug-resistant epilepsy occurred in 30% of all our patients with Rett syndrome and in 38% of those with epilepsy. Our findings demonstrate that epilepsy differs among the various phenotypes and genotypes with respect to age at onset, drug responsiveness, and seizure semiology. The Hanefeld and preserved speech variants represent the extremes of the range of severity of epilepsy: the preserved speech variant is characterized by the mildest epileptic phenotype as epilepsy is much less frequent, starts later, and is less drug resistant than what is observed in the other phenotypes. Another important finding is that seizure onset before 1 year of age and daily frequency are risk factors for drug resistance. Thus, this study should help clinicians provide better clinical counseling to the families of patients with Rett syndrome.

Epilepsy in Rett syndrome : clinical and genetic features / M. Pintaudi, M.G. Calevo, A. Vignoli, E. Parodi, F. Aiello, M.G. Baglietto, Y. Hayek, S. Buoni, A. Renieri, S. Russo, F. Cogliati, L. Giordano, M.P. Canevini, E. Veneselli. - In: EPILEPSY & BEHAVIOR. - ISSN 1525-5050. - 19:3(2010 Nov), pp. 296-300.

Epilepsy in Rett syndrome : clinical and genetic features

A. Vignoli;M.P. Canevini
Penultimo
;
2010

Abstract

Epilepsy often occurs in Rett syndrome and is considered a major problem. The aim of this study was to define the clinical features of epilepsy and the correlation between seizures and both genotype and clinical phenotype in the Rett population. One hundred sixty-five patients with Rett syndrome referred to four Italian centers were recruited. All patients underwent video/EEG monitoring and molecular analysis of the MECP2 gene or, in negative cases, of the CDKL5 and FOXG1 genes. The frequency of epilepsy was 79%. Drug-resistant epilepsy occurred in 30% of all our patients with Rett syndrome and in 38% of those with epilepsy. Our findings demonstrate that epilepsy differs among the various phenotypes and genotypes with respect to age at onset, drug responsiveness, and seizure semiology. The Hanefeld and preserved speech variants represent the extremes of the range of severity of epilepsy: the preserved speech variant is characterized by the mildest epileptic phenotype as epilepsy is much less frequent, starts later, and is less drug resistant than what is observed in the other phenotypes. Another important finding is that seizure onset before 1 year of age and daily frequency are risk factors for drug resistance. Thus, this study should help clinicians provide better clinical counseling to the families of patients with Rett syndrome.
Drug resistance; Epilepsy; Genotype-phenotype correlation; Rett syndrome; Risk factors; Seizure semiology
Settore MED/39 - Neuropsichiatria Infantile
nov-2010
Article (author)
File in questo prodotto:
File Dimensione Formato  
Pintaudi-M._Epilepsy-in-Rett-syndrome-Clinical-and-genetic-features_2010.pdf

accesso aperto

Tipologia: Publisher's version/PDF
Dimensione 257.22 kB
Formato Adobe PDF
257.22 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2434/223668
Citazioni
  • ???jsp.display-item.citation.pmc??? 26
  • Scopus 65
  • ???jsp.display-item.citation.isi??? 63
social impact